Allegan-based Perrigo Co. announced that it has entered into an exclusive agreement with Salem, N.H.-based AgaMatrix Inc. to sell and distribute blood glucose monitors and test strips in the United States store brand market
Under the settlement, Allegan-based Perrigo can begin making a generic version of Rogaine (Minoxidil) Foam no later than March 1, 2012
The Allegan generic drug and store brand health and beauty products maker Perrigo Co. Tuesday reported sharply higher sales and revenue for its second fiscal quarter and six months, ended Dec. 25.
Allegan-based Perrigo Co. announced that its board of directors declared a quarterly dividend of 7 cents a share, payable on March 15 to shareholders of record on Feb. 25.
Allegan-based Perrigo Co. Thursday announced that it has signed a definitive agreement to acquire substantially all of the assets of Paddock Laboratories Inc., a privately-held, Minneapolis-based manufacturer and marketer of generic pharmaceutical products, for approximately $540 million in cash
Allegan-based Perrigo Co. (Nasdaq: PRGO) Monday announced the launch of two new generic drugs — Naproxen Sodium Soft Gels, equivalent of Bayer’s analgesic Aleve, and levocetirizine tablets, a generic version of Xyzal allergy tablets from […]
The Allegan generic pharmaceutical and health products maker Perrigo Co. (Nasdaq: PRGO) Tuesday reported net income of $74.4 million or 80 cents a share in its fiscal first quarter ended Sept. 25. That’s a record, […]
The Allegan generic drug and health care product manufacturer Perrigo Co. Wednesday announced that its board declared a quarterly dividend of seven cents per share. The dividend is payable Dec. 14 to shareholders of record […]
Allegan-based Perrigo Co. (Nasdaq: PRGO) announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for omeprazole 20mg/sodium bicarbonate 1100mg, the generic equivalent of Zegerid OTC, and that […]
Allegan-based Perrigo Co. Wednesday announced it received FDA approval from the United States Food and Drug Administration to manufacture and market Imiquimod Cream, 5 percent. Perrigo will vertically integrate this product with their own API. […]